We appreciate the positive remarks from Quach and colleagues in response to our manuscript.1 2 The authors propose that endoscopic staging should replace non-targeted mapping biopsies in individuals at increased risk of harbouring gastric intestinal metaplasia (GIM), citing that endoscopic staging using the endoscopic grading of GIM (EGGIM) score (1) is a more resource-sensitive approach; (2) avoids the small added risk of biopsies; (3) can be performed effectively among adequately trained endoscopists; and (4) correlates with histological severity as measured via the operative link on gastric intestinal metaplasia assessment (OLGIM), at least based on a multicentre European study among trained endoscopists and external validation in a single-centre study from South Korea.3 4 Overall, we are conceptually aligned with the authors on these points. However, the theme of our article was a …

中文翻译：

---

胃肠化生的内窥镜分层：我们在哪里，我们想去哪里，我们如何到达那里？


我们感谢 Quach 及其同事对我们手稿的积极评价。2 作者建议，对于胃肠上皮化生 （GIM） 风险增加的个体，内窥镜分期应取代非靶向标测活检，并指出使用 GIM 的内窥镜分级 （EGGIM） 评分 （1） 的内窥镜分期是一种对资源更敏感的方法;（2） 避免了活检的小额外风险;（3） 可以在受过充分培训的内窥镜医师中有效进行;（4） 与通过手术联系测量的组织学严重程度相关胃肠上皮化生评估 （OLGIM），至少基于训练有素的内窥镜医师的多中心欧洲研究和韩国单中心研究的外部验证3 4 总体而言，我们在这些观点上与作者在概念上一致。然而，我们文章的主题是......